Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.
Zacks Investment Research on MSN
PLSE shares positive first-in-human nPulse cardiac catheter data
Pulse Biosciences PLSE recently announced late-breaking data from its first-in-human feasibility study of the nPulse Cardiac ...
Boston Scientific has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib.
The heart is at the center of a complex electrical system. Just like any machine, sometimes the system does not always work correctly. There may be a short circuit. This could lead to an abnormal or ...
Dr. Yang Yang is an electrophysiologist at the Washington Regional Electrophysiology Clinic, part of the Walker Heart ...
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...
If medications and lifestyle changes are still not improving your atrial fibrillation symptoms, it may be time to consider a surgical option. Cardiovascular surgeon Jared Bunch, MD, discusses cardiac ...
At 1 year, nearly 80% of patients with atrial fibrillation treated with an FDA-approved spherical pulsed field ablation ...
LA Chargers coach Jim Harbaugh is having a cardiac ablation during the offseason. It's a procedure to treat an irregular heart rhythm. The procedure involves creating tiny scars in the heart that then ...
Volt Pulsed Field Ablation System (PFA) is being trialed for the first time in the UK at Belfast Royal Victoria Hospital (RVH ...
The need for aFIB awareness is growing, with a recent study by the CDC projecting a huge spike in cases by 2030—over 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results